Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Semin Neurol 2005; 25(2): 229-237
DOI: 10.1055/s-2005-871331
DOI: 10.1055/s-2005-871331
Rehabilitation Management of Peripheral Neuropathy
Gregory T. Carter1Further Information
Publication History
Publication Date:
03 June 2005 (online)
ABSTRACT
The goals of rehabilitation for patients with peripheral neuropathy are to maximize and prolong independent and safe locomotion and function, inhibit physical deformity, and provide access to full integration into society. The services of multiple disciplines are required to fully achieve these goals and include physicians, nurses, therapists, orthotists, social and vocational counselors, and psychologists. Treatment is goal-oriented, using various modalities including exercise, bracing, adaptive equipment, medication, and surgery.
KEYWORDS
Peripheral neuropathy - rehabilitation - neuropathic pain - orthotics - neuromuscular disease
REFERENCES
- 1 Emery A H. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord. 1991; 1 19-29
- 2 Carter G T, Abresch R T, Fowler W M et al.. Profiles of neuromuscular disease: hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil. 1995; 74 S140-S149
- 3 Carter G T. Neuromuscular disorders. In: Dell Orto AE, Marinelli RP Encyclopedia of Disability and Rehabilitation. New York; Simon & Schuster MacMillan 1995: 509-515
- 4 Fowler W M, Abresch R T, Aitkens S A, Carter G T. Impairment and disability profiles of neuromuscular diseases: design of the protocol. Am J Phys Med Rehabil. 1995; 74 62-69
- 5 Fowler W M, Carter G T, Kraft G H. Role of physiatry in the management of neuromuscular disease. Phys Med Rehabil Clin N Am. 1998; 9 1-8
-
6 Carter G T. e-Medicine: rehabilitation management of neuromuscular disease. Physical Medicine and Rehabititation. http://Available at: www.emedicine.com/pmr/topic 233.htm
- 7 Carter G T, England J D, Hecht T W, Han J, Weydt P, Chance P. Electrodiagnosis of hereditary motor and sensory neuropathies. Phys Med Rehabil Clin N Am. 2003; 14 347-363
- 8 Carter G T, England J D, Chance P F. Charcot-Marie-Tooth disease: electrophysiology, molecular biology, and clinical management. IDrugs. 2004; 7 151-159
- 9 Ionasescu V V. Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics. Muscle Nerve. 1995; 18 267-275
- 10 Lindeman E, Leffers P, Reulen J, Spaans F, Drukker J. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil. 1998; 12 127-135
- 11 Lindeman E, Leffers P, Reulen J et al.. Reduction of knee torques and leg-related functional abilities in hereditary motor and sensory neuropathy. Arch Phys Med Rehabil. 1994; 75 1201-1205
- 12 Kilmer D D, Aitkens S G, Wright N C et al.. Simulated work performance tasks in persons with neuropathic and myopathic weakness. Arch Phys Med Rehabil. 2000; 81 938-943
- 13 Aitkens S G, McCrory M A, Kilmer D D, Bernauer E M. Moderate resistance exercise program: its effects in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993; 74 711-715
- 14 Kilmer D D, McCrory M A, Wright N C, Aitkens S G, Bernauer E M. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994; 75 560-563
- 15 Kilmer D D. Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002; 81 S148-S150
- 16 Kilmer D D. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002; 81 S121-S126
- 17 Kilmer D D. The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am. 1998; 9 115-125
- 18 Lindeman E, Leffers P, Spaans F et al.. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995; 76 612-620
- 19 Kilmer D D, Mcrory M A, Wright N C et al.. Hand held dynamometry reliability in persons with neuropathic weakness. Arch Phys Med Rehabil. 1997; 78 1364-1368
- 20 Carter G T, Kikuchi N, Abresch R T, Walsh S A, Horasek S, Fowler W M. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil. 1994; 75 555-559
- 21 Carter G T, Abresch R T, Fowler W M. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease. Am J Phys Med Rehabil. 2002; 81(suppl) S151-S161
- 22 Breslin E, Booth J, Lord B et al.. Respiratory responses to unsupported arm exercise (UAE) in Charcot Marie Tooth (CMT) [abstract]. American Thoracic Society. Am Rev Respir Dis. 1993; 147 532A
- 23 Breslin E H, Carter G T, Mercer K, Bonekat H W, Lee K. Fatigue in patients with Charcot-Marie-Tooth [abstract]. Arch Phys Med Rehabil. 1993; 74 A1256-A1257
- 24 Videler A J, Beelen A, Aufdemkampe G et al.. Hand strength and fatigue in patients with hereditary motor and sensory neuropathy (types I and II). Arch Phys Med Rehabil. 2002; 83 1274-1278
- 25 Carter G T, Kilmer D D, Szabo R M, McDonald C M. Focal posterior interosseus neuropathy in the presence of hereditary motor and sensory neuropathy, type I. Muscle Nerve. 1996; 19 644-648
- 26 McDonald C M. Limb contracture in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am. 1998; 9 187-212
- 27 Paulson L E, Kilmer D D. Orthotic management in peripheral neuropathy. Phys Med Rehabil Clin N Am. 2001; 12 433-445
- 28 Boninger M L, Leonard Jr J A. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions. J Rehabil Res Dev. 1996; 33 16-19
- 29 Bean J, Walsh A, Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease: a single-subject design. Am J Phys Med Rehabil. 2001; 80 578-582
- 30 Perry J. Normal and pathological gait. In: Goldberg B, Hsu JD Atlas of Orthoses and Assistive Devices. 3rd ed. St. Louis; Mosby 1997: 295-304
- 31 Helm P A, Walker S C, Pullium G. Total contact casting in diabetics with neuropathic foot ulcerations. Arch Phys Med Rehabil. 1984; 65 691-695
- 32 Helm P A, Walker S C, Pullium G F. Recurrence of neuropathic ulceration following healing in a total contact cast. Arch Phys Med Rehabil. 1991; 72 967-975
- 33 King S, Thomas J J, Rice M S. The immediate and short-term effects of a wrist extension orthosis on upper-extremity kinematics and range of shoulder motion. Am J Occup Ther. 2003; 57 517-524
- 34 Schon L C, Easley M E, Weinfeld S B. Charcot neuroarthropathy of the foot and ankle. Clin Orthop. 1998; 349 116-117
- 35 Sella E J, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999; 38 34-45
- 36 Sinacore D R, Withrington N C. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999; 29 736-741
- 37 Walker S C, Helm P A, Pullium G. Total contact casting and chronic diabetic neuropathic foot ulcerations: healing rates by wound location. Arch Phys Med Rehabil. 1987; 68 217-223
- 38 Mehta J A, Brown C, Sargeant N. Charcot restraint orthotic walker. Foot Ankle Int. 1998; 19 619-624
- 39 Morgan J M, Biehl III W C, Wagner F W. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop. 1993; 296 58-64
- 40 Carter G T, Jensen M P, Galer B S et al.. Neuropathic pain in Charcot Marie Tooth disease. Arch Phys Med Rehabil. 1998; 79 1560-1564
- 41 Moulin D E, Hagen N, Feasby T E, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology. 1997; 48 328-331
- 42 Carter G T, Galer B S. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am. 2001; 12 447-460
- 43 Abresch R T, Jensen M P, Carter G T. Health quality of life in peripheral neuropathy. Phys Med Rehabil Clin N Am. 2001; 12 461-472
- 44 Abresch R T, Carter G T, Jensen M P, Kilmer D D. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002; 19 39-48
- 45 Backonja M M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia. 1999; 40 S57-S59
- 46 Beydoun A. Postherpetic neuralgia: role of gabapentin and other treatment modalities. Epilepsia. 1999; 40 S51-S56
- 47 Magnus L. Nonepileptic uses of gabapentin. Epilepsia. 1999; 40 S66-S72
- 48 McQuay H, Carroll D, Jadad A R et al.. Anticonvulsant drugs for management of pain: a systemic review. BMJ. 1995; 311 1047-1052
- 49 Morello C M, Leckband S G, Stoner C P et al.. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999; 159 1931-1937
- 50 Carter G T, Sullivan M D. Antidepressants in pain management. Curr Opin Investig Drugs. 2002; 3 454-458
- 51 Kingery W S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997; 73 123-139
- 52 Max M B, Culnane M, Schafer S C et al.. Amitriptyline relieves diabetic neuropathy pain in patients with normal depressed mood. Neurology. 1987; 37 589-596
- 53 Max M B, Lynch S A, Muir J et al.. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992; 326 1250-1252
- 54 Watson C P, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998; 51 1166-1171
- 55 Taylor K, Rowbotham M C. Venlafaxine hydrochloride and chronic pain. West J Med. 1996; 165 147-148
- 56 Galer B S, Harle J, Rowbotham M C. Response to intravenous lidocaine infusion predicts subsequent response to oral mexilitine: a prospective study. J Pain Symptom Manage. 1996; 12 161-167
- 57 Galer B S, Miller K V, Rowbotham M C. Response to intravenous lidocaine differs based on clinical diagnosis and site of nervous system injury. Neurology. 1993; 43 1233-1235
- 58 Galer B S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995; 45 17-25
- 59 Galer B S, Rowbotham M C, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle patch: results of an enriched enrollment study. Pain. 1999; 80 533-538
- 60 Galer B S. Painful polyneuropathy. Neurol Clin. 1998; 16 791-812
- 61 Duhmke R M, Cornblath D D, Hollingshead J R. Tramadol for neuropathic pain. Cochraine Database Syst Rev. 2004; (2) CD003726
- 62 Watson C P, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998; 50 1837-1841
- 63 Jay C, Shade S, Vizoso H et al.. The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: results of an open-label pilot study. Proceedings of the 11th Conference on Retroviruses and Opportunistic Infections. 2004 496: A243 (Abstract)
- 64 Wade D T, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil. 2003; 17 21-29
- 65 Carter G T, Rosen B S. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2001; 18 264-270
- 66 Carter G T, Weydt P. Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs. 2002; 3 437-440
- 67 Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001; 178 98-105
- 68 Rice A SC. Cannabinoids and pain. Curr Opin Investig Drugs. 2001; 2 399-414
Gregory T CarterM.D.
1809 Cooks Hill Road
Centralia, WA 98531